摘要
多发性骨髓瘤是以浆细胞恶性克隆增殖为特征的一种血液系统恶性疾病,虽然靶向药物及干细胞移植的广泛应用有效改善了多发性骨髓瘤的缓解率及生存期,但疾病仍会复发、以至难治。在治疗过程中,应充分考虑患者及疾病特点,从而采取更加合理的治疗方案。
Multiple myeloma is plasma cells malignant cloual proliferation characteristics of a malignant disease of the blood, although the targeted drugs and the wide application of stem cell transplantation can improve the response rate of multiple myeloma and survival, but still disease relapse, and refractory. In the process of treatment, should give full consideration to the patient and disease characteristics, and to adopt a more reasonable treatment plan.
出处
《世界中医药》
CAS
2016年第B06期2068-2069,共2页
World Chinese Medicine
关键词
多发性骨髓瘤
复发
难治
干细胞移植
multiple myeloma
recurrence
refractory
stem cell transplantation